{
  "id": 20286706,
  "title": "Lilly adds to buyout streak with $1.5B purchase of startup Calytrix",
  "url": "https://urgent.news/2026/11/16/lilly-adds-to-buyout-streak-with-1-5b-purchase-of-startup-calytrix",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-11-16T12:44:00.000Z",
  "source": {
    "name": "BioPharma Dive",
    "slug": "biopharma-dive",
    "url": "https://www.biopharmadive.com/news/lilly-calytrix-bio-acquire-deal-myelofibrosis-essential-thrombocythemiaenial-/874719/"
  },
  "original_language": "en",
  "account": null,
  "summary": "Lilly’s 15th announced company acquisition this year — by far the most in the biopharmaceutical sector — centers around a precision therapy for rare blood disorders known as myeloproliferative neoplasms.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}